Resources for You

Inhibitor development is the most severe treatment challenge that can affect anyone with hemophilia A at any time.1,2 Utilize the resources on this page to learn how the results from the SIPPET study may affect you.


Learn more about inhibitors and SIPPET from leading hematologists.

Dr. Flora Peyvandi

Hematologist, Italy

Dr. Steve Austin

Hematologist, United Kingdom

Dr. Angelika Batorova

Hematologist, Slovakia



  1. Srivastava A, Brewer AK, Mauser-Bunschonten EP, et al; Treatment Guidelines Working Group. Guidelines for the Management of Hemophilia. 2nd Ed. Montreal, Canada: World Federation of Hemophilia; 2012.
  2. Hay CR e.t al. Incidence of factor VIII inhibitors throughout life in severe hemophilia A in the United Kingdom. Blood. 2011; 117(23):6367-6370.
  3. Hemophilia Federation of America. What is hemophilia? Hemophilia Federation of America website. http://hemophiliafed.org/bleeding-disorders/hemophilia/. Accessed June 16, 2016.